These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 415194)

  • 1. Influence of adrenergic antagonists and apomorphine on prolactin release induced by serotonergic antagonists in the monkey.
    Gala RR; Peters JA; Pieper DR; Campbell MD
    Life Sci; 1978 Jan; 22(1):25-30. PubMed ID: 415194
    [No Abstract]   [Full Text] [Related]  

  • 2. The effects of serotonergic and adrenergic receptor antagonist on prolactin release in the monkey.
    Gala RR; Subramanian MG; Peters JA; Pieper DR
    Life Sci; 1977 Feb; 20(4):631-7. PubMed ID: 14291
    [No Abstract]   [Full Text] [Related]  

  • 3. Influence of serotonergic and adrenergic antagonists on TRH-induced prolactin release in the monkey.
    Gala RR; Peters JA; Pieper DR; Subramanian MG
    Life Sci; 1978 Feb; 22(6):439-43. PubMed ID: 415195
    [No Abstract]   [Full Text] [Related]  

  • 4. Effects of centrally acting drugs on serum prolactin levels in rhesus monkeys.
    Quadri SK; Pierson C; Spies HG
    Neuroendocrinology; 1978; 27(3-4):136-47. PubMed ID: 104186
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Further studies on the effects of adrenergic, serotonergic and cholinergic drugs on the afternoon surge of plasma prolactin in ovariectomized, estrogen-treated rats.
    Subramanian MG; Gala RR
    Neuroendocrinology; 1976; 22(3):240-9. PubMed ID: 1028955
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The influence of cholinergic, adrenergic, and serotonergic drugs on the afternoon surge of plasma prolactin in ovariectomized, estrogen-treated rats.
    Subramanian MG; Gala RR
    Endocrinology; 1976 Apr; 98(4):842-8. PubMed ID: 1278094
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of receptor blocking drugs on the depletion of brain glycogen by amphetamine.
    Hutchins DA; Rogers KJ
    Br J Pharmacol; 1971 Nov; 43(3):504-13. PubMed ID: 4400527
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The influence of adrenergic, dopaminergic, cholinergic and serotoninergic drugs on plasma prolactin levels in ovariectomized, estrogen-treated rats.
    Lawson DM; Gala RR
    Endocrinology; 1975 Feb; 96(2):313-8. PubMed ID: 234380
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lack of evidence that the central serotoninergic system plays a role in the activation of prolactin secretion following inhibition of dopamine synthesis or blockade of dopamine receptors in the male rat.
    Krulich L; Coppings RJ; Giachetti A; McCann SM; Mayfield MA
    Neuroendocrinology; 1980; 30(3):133-8. PubMed ID: 6445044
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of dopaminergic agonists and antagonists on isolated cerebral blood vessels.
    Edvinsson L; Hardebo JE; McCulloch J; Owman C
    Acta Physiol Scand; 1978 Nov; 104(3):349-59. PubMed ID: 716985
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Potentiation of insulin secretion in vitro by serotonin antagonists.
    Feldman JM; Quickel KE; Lebovitz HE
    Diabetes; 1972 Jul; 21(7):779-88. PubMed ID: 4402679
    [No Abstract]   [Full Text] [Related]  

  • 12. The influence of neural blocking agents injected into the third ventricle of the rat brain and hypothalamic electrical stimulation on serum prolactin.
    Gala RR; Janson PA; Kuo EY
    Proc Soc Exp Biol Med; 1972 Jun; 140(2):569-72. PubMed ID: 4402578
    [No Abstract]   [Full Text] [Related]  

  • 13. On the mode of the prolactin release-inhibiting action of the serotonin receptor blockers metergoline, methysergide, and cyproheptadine.
    Krulich L; McCann SM; Mayfield MA
    Endocrinology; 1981 Apr; 108(4):1115-24. PubMed ID: 7472261
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The pharmacologic blockade of the circhoral mode of LH secretion in the ovariectomized rhesus monkey.
    Bhattacharya AN; Dierschke DJ; Yamaji T; Knobil E
    Endocrinology; 1972 Mar; 90(3):778-86. PubMed ID: 4400337
    [No Abstract]   [Full Text] [Related]  

  • 15. Vasomotor response of cerebral blood vessels to dopamine and dopaminergic agonists.
    Edvinsson L; Hardebo JE; McCulloch J; Owman C
    Adv Neurol; 1978; 20():85-96. PubMed ID: 676925
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cocaine cue in rats as it relates to subjective drug effects: a preliminary report.
    Colpaert FC; Niemegeers CJ; Janssen PA
    Eur J Pharmacol; 1976 Nov; 40(1):195-9. PubMed ID: 991926
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of alpha-adrenergic blocking agents on stereotyped behavior induced by apomorphine in rats.
    De-Souza H; Palermo-Neto J
    Braz J Med Biol Res; 1982 Jul; 15(2-3):143-6. PubMed ID: 6891277
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An investigation on the behavioral and hypothermic effects of yohimbine: interaction with drugs affecting central and peripheral monoamines.
    Papeschi R
    Arch Int Pharmacodyn Ther; 1974 Mar; 208(1):61-80. PubMed ID: 4276928
    [No Abstract]   [Full Text] [Related]  

  • 19. The action of para-methoxyphenylethylamine (PMPEA) on monosynaptic reflex transmission in the cat.
    Walker RJ; Willis JC; Willis WD
    Br J Pharmacol; 1970 Jan; 38(1):106-16. PubMed ID: 5413281
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of estrogen-induced elevation of cyclic 3',5'-adenosine monophosphate in rat uterus. I. By beta-adrenergic receptor-blocking drugs.
    Szego CM; Davis JS
    Mol Pharmacol; 1969 Sep; 5(5):470-80. PubMed ID: 4390446
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.